Literature DB >> 19947833

Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences.

Rafael Galvez1.   

Abstract

According to the 2005 Pain in Europe Survey, the use of opioids to treat patients with chronic noncancer pain varies considerably among different countries in Europe. Undertreatment of chronic pain is common. This review examines the possible causes and consequences of limiting opioid availability to these patients. The causes of inadequate opioid use include medical, ethical, and cultural factors that influence prescribing decisions; legislative and health care system controls that serve to restrict the use of opioids for long-term treatment of non-cancer-related pain conditions; and poor treatment acceptance by patients. The validity of these restrictions is discussed in relation to the need to protect patients and society from harm due to adverse events, and the potential for misuse and abuse with prescribed opioids. This is balanced against the therapeutic goal of providing the best available pain-relieving treatment and to avoid the consequences of unnecessary suffering in patients with chronic noncancer pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19947833     DOI: 10.3109/15360280903323665

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  5 in total

Review 1.  [Pain therapy in emergency medicine. Focus on emergency admissions].

Authors:  B Kumle; P Wilke; W Koppert; K Kumle; A Gries
Journal:  Anaesthesist       Date:  2013-11       Impact factor: 1.041

2.  Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR).

Authors:  Nienke te Boveldt; Yvonne Engels; Kees Besse; Kris Vissers; Myrra Vernooij-Dassen
Journal:  Implement Sci       Date:  2011-12-06       Impact factor: 7.327

3.  Treatment profiles and costs of patients with chronic pain in the population setting.

Authors:  Antoni Sicras Mainar; Ruth Navarro Artieda; Jesús Villoria Morillo; Ana Esquivias Escobar
Journal:  Clinicoecon Outcomes Res       Date:  2012-01-26

4.  Does a Screening Trial for Spinal Cord Stimulation in Patients with Chronic Pain of Neuropathic Origin have Clinical Utility and Cost-Effectiveness? (TRIAL-STIM Study): study protocol for a randomised controlled trial.

Authors:  Sam Eldabe; Ashish Gulve; Simon Thomson; Ganesan Baranidharan; Rui Duarte; Susan Jowett; Harbinder Sandhu; Raymond Chadwick; Morag Brookes; Anisah Tariq; Jenny Earle; Jill Bell; Anu Kansal; Shelley Rhodes; Rod S Taylor
Journal:  Trials       Date:  2018-11-16       Impact factor: 2.279

5.  Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.

Authors:  Benedikt Fischer; Wayne Jones; Jürgen Rehm
Journal:  BMC Health Serv Res       Date:  2014-02-26       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.